Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Astera Labs (ALAB) EBT Margin (2023 - 2025)

Astera Labs has reported EBT Margin over the past 3 years, most recently at 29.16% for Q4 2025.

  • For the quarter ending Q4 2025, EBT Margin rose 2158.0% year-over-year to 29.16%, compared with a TTM value of 25.59% through Dec 2025, up 4622.0%, and an annual FY2025 reading of 25.59%, up 4622.0% over the prior year.
  • EBT Margin came in at 29.16% for Q4 2025, up from 29.0% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 29.16% in Q4 2025 to a low of 150.24% in Q2 2023.
  • Median EBT Margin over the past 3 years was 4.68% (2024), compared with a mean of 21.82%.
  • The sharpest move saw EBT Margin plummeted -2511bps in 2024, then skyrocketed 13684bps in 2025.
  • Over 3 years, EBT Margin stood at 21.17% in 2023, then crashed by -64bps to 7.58% in 2024, then surged by 285bps to 29.16% in 2025.
  • Per Business Quant, the three most recent readings for ALAB's EBT Margin are 29.16% (Q4 2025), 29.0% (Q3 2025), and 26.4% (Q2 2025).